Search Results - "pharmacodynamics"
-
1
Pharmacodynamics for Medical Students
Published 2014“…A video primer on pharmacodynamics to enable medical students to understand the basic terminology and be able to interpret receptor binding and dose response...…”
Get full text
Get full text
-
2
Pharmacodynamics and pharmacokinetics of phenylbutazone in calves
Published 2002“…Phenylbutazone (PBZ) was administered to six calves intravenously (i.v.) and orally at a dose rate of 4.4 mg/kg in a three-period cross-over study incorporating a placebo treatment to establish its pharmacokinetic and pharmacodynamic properties. Extravascular distribution was determined by measuring penetration into tissue chamber fluid in the absence of stimulation (transudate) and after stimulation of chamber tissue with the mild irritant carrageenan (exudate). …”
Get full text
Get full text
-
3
Ketoprofen in the Cat: Pharmacodynamics and Chiral Pharmacokinetics
Published 2003“…The non-steroidal anti-inflammatory drug ketoprofen (KTP) was administered as the racemate to cats intravenously (IV) and orally at clinically recommended dose rates of 2 and 1 mg/kg, respectively, to establish its chiral pharmacokinetic and pharmacodynamic properties. After IV dosing, clearance was more than five times greater and elimination half-life and mean residence time were approximately three times shorter for R(−) KTP than for S(+) KTP. …”
Get full text
Get full text
-
4
-
5
Pharmacodynamics and pharmacokinetics of ketoprofen enantiomers in sheep
Published 2001“…Objective - To establish pharmacokinetic and pharmacodynamic properties of a racemic mixture and individual R(-) and S(+) enantiomeric forms of ketoprofen (KTP) in sheep and determine pharmacodynamic variables of KTP by pharmacokinetic-pharmacodynamic modeling. …”
Get full text
Get full text
-
6
Development of a Pharmacodynamic Model of Murine Malaria
Published 2015“…The rational design of antimalarial therapies has historically been compromised by a paucity of pharmacodynamic data contributing to resistance through deployment of suboptimal doses. …”
Get full text
-
7
-
8
-
9
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
Published 2013“…An understanding of the pharmacokinetics and pharmacodynamics of mycophenolate in this population should assist the clinician with rational dosage decisions. …”
Get full text
Get full text
-
10
-
11
Pharmacodynamic studies of antimalarial drugs in a murine malaria model
Published 2011Subjects: Get full text
-
12
-
13
Pharmacodynamics, chiral pharmacokinetics and PK–PD modelling of ketoprofen in the goat
Published 2003“…The pharmacokinetics and pharmacodynamics of KTP were investigated using a tissue cage model of acute inflammation. …”
Get full text
Get full text
-
14
Pharmacodynamics, chiral pharmacokinetics and PK-PD modelling of ketoprofen in the goat
Published 2003“…The pharmacokinetics and pharmacodynamics of KTP were investigated using a tissue cage model of acute inflammation. …”
Get full text
Get full text
-
15
Mechanism-based model of parasite growth and dihydroartemisinin pharmacodynamics in murine malaria
Published 2013“…Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) models for antimalarials are scarce, despite their potential to optimize antimalarial combination therapy. …”
Get full text
-
16
Pharmacokinetics, Pharmacodynamics and Allometric Scaling of Chloroquine in a Murine Malaria Model
Published 2011“…The single-dose pharmacodynamic study (10 to 50 mg CQ/kg of body weight) showed dose-related reduction in parasitemia (5- to >500-fold) and a nadir 2 days after the dose. …”
Get full text
-
17
-
18
Pharmacokinetic and pharmacodynamic features of nanoemulsion following oral, intravenous, topical and nasal route
Published 2017“…Keywords: Hydrophobicity, oral delivery, pharmacokinetics, pharmacodynamics, routes of administration.…”
Get full text
Get full text
Get full text
Get full text
Get full text
-
19
-
20
Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development
Published 2015“…Optimal and timely pharmacokinetic/pharmacodynamic (PK/PD) target attainment has been associated with an increased likelihood of clinical andmicrobiological success in critically ill patients. …”
Get full text
Get full text